IL27 and graft versus host disease: It is indeed possible that IL-27 may drive aGVHD and that precluding IL-27 signaling to T cells may lessen GVHD resulting in lower proinflammatory cytokine production that then allows pTregs to be generated in vivo and contribute to protective effects.